Form 4 for CLPT ClearPoint Neuro, Inc.

Accepted 2025-03-10 00:00:00 ET · period of report 2025-03-06 · accession 0000950170-25-036675 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2025-03-10	2025-03-06	CLPT	STIGALL L. JEREMY	Chief Business Off	M - OptEx	—	+17.8K	65.4K	+37%	—
D	2025-03-10	2025-03-06	CLPT	STIGALL L. JEREMY	Chief Business Off	F - Tax	$13.19	-6,361	59.0K	-10%	-$83.9K
D	2025-03-10	2025-03-06	CLPT	STIGALL L. JEREMY	Chief Business Off	M - OptEx	—	-17.8K	17.8K	-50%	—

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2025-03-06	M	A	17,777	—	65,392	D	—	—	(F1) Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date.
2	Common	Common Stock	2025-03-06	F	D	6,361	$13.19	59,031	D	—	—	(F2) Represents the amount of shares delivered to CLPT to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock.
3	Derivative	Restricted Stock Units	2025-03-06	M	D	17,777	—	17,778	D	— · — to —	17,777 Common Stock	(F1) Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date.